AbD Serotec

AbD Serotec of Martinsried, Germany, and e2v biosensors of Chelmsford, UK, have launched a research program to perform feasibility studies showing proof of concept of the British company’s Visucare biosensor system. The system, a detection technology for biomarkers that uses a single-antibody immunoassay, will be used for protein quantification in point-of-care and near-patient testing.





LATEST NEWS

• The Winds of Change Are Blowing Through the Photonics Industry
  May 3, 2024
• PsiQuantum to Build Utility-Scale Quantum Computer in Australia
  May 3, 2024
• Tyndall, MIT Partner on Sustainable Chip Production Processes: Week in Brief: 5/3/24
  May 3, 2024
• Headwall Taps Jim Gareau to Lead Optical Components and Assemblies Unit
  May 2, 2024
• Cognex Names Former Siemens VP Dennis Fehr CFO
  May 2, 2024
• 3D Holography Integrated Glasses Could Unlock Mixed Reality
  May 2, 2024
• Generative AI Achieves Superresolution with Minimal Tuning
  May 2, 2024
• AmeriCOM Adds President and CEO: People in the News: 5/1/24
  May 1, 2024